Treace Medical Concepts annual r&d spending
2019
2020
2021
2022
2023
2024
2025
Treace Medical Concepts R&D Spending Growth & History (TMCI)
Treace Medical Concepts's r&d spending was $20.3M for fiscal 2025.
View full Treace Medical Concepts company overviewTreace Medical Concepts annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.3M | −$307,000 | −1.49% |
| 2024 | 2024-12-31 | $20.6M | $5.1M | +33.35% |
| 2023 | 2023-12-31 | $15.4M | $1.9M | +13.66% |
| 2022 | 2022-12-31 | $13.6M | $3.4M | +33.12% |
| 2021 | 2021-12-31 | $10.2M | $4.4M | +74.52% |
| 2020 | 2020-12-31 | $5.8M | $777,000 | +15.33% |
| 2019 | 2019-12-31 | $5.1M | — | — |
Treace Medical Concepts quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.4M | −$1.1M | −20.41% |
| Q1 2026 | 2026-03-31 | $4.6M | −$940,000 | −16.90% |
| Q4 2025 | 2025-12-31 | $4.5M | −$668,000 | −12.82% |
| Q3 2025 | 2025-09-30 | $4.7M | −$283,000 | −5.70% |
| Q2 2025 | 2025-06-30 | $5.5M | $341,000 | +6.61% |
| Q1 2025 | 2025-03-31 | $5.6M | $303,000 | +5.76% |
| Q4 2024 | 2024-12-31 | $5.2M | $1.1M | +25.48% |
| Q3 2024 | 2024-09-30 | $5.0M | $613,000 | +14.09% |
| Q2 2024 | 2024-06-30 | $5.2M | $1.6M | +46.26% |
| Q1 2024 | 2024-03-31 | $5.3M | $1.8M | +54.13% |
| Q4 2023 | 2023-12-31 | $4.2M | $403,000 | +10.75% |
| Q3 2023 | 2023-09-30 | $4.3M | $551,000 | +14.50% |
| Q2 2023 | 2023-06-30 | $3.5M | $542,000 | +18.16% |
| Q1 2023 | 2023-03-31 | $3.4M | $360,000 | +11.80% |
| Q4 2022 | 2022-12-31 | $3.7M | $372,000 | +11.02% |
| Q3 2022 | 2022-09-30 | $3.8M | $1.3M | +49.74% |
| Q2 2022 | 2022-06-30 | $3.0M | $562,000 | +23.20% |
| Q1 2022 | 2022-03-31 | $3.1M | $1.2M | +63.38% |
| Q4 2021 | 2021-12-31 | $3.4M | $1.5M | +75.79% |
| Q3 2021 | 2021-09-30 | $2.5M | $1.0M | +67.90% |
| Q2 2021 | 2021-06-30 | $2.4M | $1.4M | +146.64% |
| Q1 2021 | 2021-03-31 | $1.9M | $435,000 | +30.36% |
| Q4 2020 | 2020-12-31 | $1.9M | — | — |
| Q3 2020 | 2020-09-30 | $1.5M | — | — |
| Q2 2020 | 2020-06-30 | $982,000 | — | — |
| Q1 2020 | 2020-03-31 | $1.4M | — | — |
Treace Medical Concepts r&d spending trends
Over the last five fiscal years, Treace Medical Concepts's r&d spending increased from $5.8M to $20.3M, a change of $14.4M. The latest reported quarter, Q2 2026, shows $4.4M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Treace Medical Concepts source filings ↗